Literature DB >> 11479198

PTEN-independent induction of caspase-mediated cell death and reduced invasion by the focal adhesion targeting domain (FAT) in human astrocytic brain tumors which highly express focal adhesion kinase (FAK).

G Jones1, J Machado, M Tolnay, A Merlo.   

Abstract

Increased expression of focal adhesion kinase (FAK) was consistently observed in low- and high-grade astrocytomas and during glioblastoma progression after radiotherapy, but not in the more benign oligodendroglioma. In glioblastoma cell lines deficient for p53, p16(INK4A), and p14(ARF), FAK was inhibited in a dominant-negative manner by the focal adhesion targeting (FAT) domain, reducing invasion. In addition, caspase-3 activity was increased after serum withdrawal, or by cisplatin in the presence of serum, or upon loss of substrate attachment, and was in each case independent of PTEN status. Our results identify FAK as a potential target for anti-invasive strategies against infiltrating glioma cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11479198

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  Focal adhesion kinase silencing augments docetaxel-mediated apoptosis in ovarian cancer cells.

Authors:  Jyotsnabaran Halder; Charles N Landen; Susan K Lutgendorf; Yang Li; Nicholas B Jennings; Dominic Fan; Gina M Nelkin; Rosemarie Schmandt; Michael D Schaller; Anil K Sood
Journal:  Clin Cancer Res       Date:  2005-12-15       Impact factor: 12.531

2.  In situ analysis of integrin and growth factor receptor signaling pathways in human glioblastomas suggests overlapping relationships with focal adhesion kinase activation.

Authors:  Markus J Riemenschneider; Wolf Mueller; Rebecca A Betensky; Gayatry Mohapatra; David N Louis
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

3.  Thymoquinone reduces migration and invasion of human glioblastoma cells associated with FAK, MMP-2 and MMP-9 down-regulation.

Authors:  Kaouther Kolli-Bouhafs; Abdelaziz Boukhari; Abdurazzag Abusnina; Emilie Velot; Jean-Pierre Gies; Claire Lugnier; Philippe Rondé
Journal:  Invest New Drugs       Date:  2011-12-15       Impact factor: 3.850

4.  AMPA receptors promote perivascular glioma invasion via beta1 integrin-dependent adhesion to the extracellular matrix.

Authors:  Yuji Piao; Li Lu; John de Groot
Journal:  Neuro Oncol       Date:  2008-10-28       Impact factor: 12.300

Review 5.  Genes and pathways driving glioblastomas in humans and murine disease models.

Authors:  Adrian Merlo
Journal:  Neurosurg Rev       Date:  2003-05-29       Impact factor: 3.042

Review 6.  Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis.

Authors:  Ming Luo; Jun-Lin Guan
Journal:  Cancer Lett       Date:  2009-07-29       Impact factor: 8.679

7.  The expression of integrinbeta1 and FAK in pituitary adenomas and their correlation with invasiveness.

Authors:  Feng Wang; Kai Shu; Ting Lei; Delin Xue
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-10-10

8.  Neurofibromin physically interacts with the N-terminal domain of focal adhesion kinase.

Authors:  Frederick Kweh; Min Zheng; Elena Kurenova; Margaret Wallace; Vita Golubovskaya; William G Cance
Journal:  Mol Carcinog       Date:  2009-11       Impact factor: 4.784

9.  Antiangiogenic and anti-invasive effects of sunitinib on experimental human glioblastoma.

Authors:  Sophie de Boüard; Paulette Herlin; James G Christensen; Edwige Lemoisson; Pascal Gauduchon; Eric Raymond; Jean-Sébastien Guillamo
Journal:  Neuro Oncol       Date:  2007-07-10       Impact factor: 12.300

10.  Discovery of novel focal adhesion kinase inhibitors using a hybrid protocol of virtual screening approach based on multicomplex-based pharmacophore and molecular docking.

Authors:  Fengbo Wu; Ting Xu; Gu He; Liang Ouyang; Bo Han; Cheng Peng; Xiangrong Song; Mingli Xiang
Journal:  Int J Mol Sci       Date:  2012-11-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.